drugset / Trial / NCT00255463
Phase II Neoadjuvant ER+/PgR + Arimidex +/- Iressa Study
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to compare the changes in a proliferation biomarker in subjects receiving Anastrozole or Anastrozole/ZD1839 combination.
Timeline
- Start
- 2004-01
- Primary completion
- —
- Completion
- 2005-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anastrozole | Other / unclassified | — | — |
| Subject | Gefitinib | Small molecule | — | — |